Corneal confocal microscopy reveals small nerve fibre loss correlating with motor function in adult spinal muscular atrophy.
Hammersmith Functional Motor Scale Expanded
biomarker
corneal confocal microscopy
motor neuron disease
small fibre neuropathy
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
revised:
20
04
2023
received:
10
03
2023
accepted:
04
05
2023
medline:
8
8
2023
pubmed:
9
5
2023
entrez:
9
5
2023
Statut:
ppublish
Résumé
5q Spinal muscular atrophy (SMA) is a progressive, inherited, and severely disabling - yet treatable - motor neuron disease. Although treatment options have evolved in recent years, biomarkers for treatment monitoring and prognosis prediction remain elusive. Here, we investigated the utility of corneal confocal microscopy (CCM), a non-invasive imaging technique to quantify small corneal nerve fibres in vivo, as a diagnostic tool in adult SMA. In this cross-sectional study, 19 patients with SMA type 3 and 19 healthy controls underwent CCM to measure corneal nerve fibre density (CNFD), corneal nerve fibre length (CNFL), and corneal nerve branch density (CNBD), as well as corneal immune cell infiltration. Hammersmith Functional Motor Scale Expanded (HFMSE) and Revised Upper Limb Module (RULM) scores and a 6-Minute Walk Test (6MWT) were conducted to explore any correlation between CCM findings and motor function. Corneal nerve fibre parameters were decreased in SMA patients versus healthy controls (CNFD: p = 0.030; CNFL: p = 0.013; CNBD: p = 0.020) in the absence of relevant immune cell infiltration. CNFD and CNFL correlated with HFMSE scores (CNFD: r = 0.492, p = 0.038; CNFL: r = 0.484, p = 0.042) and distance covered in the 6MWT (CNFD: r = 0.502, p = 0.042; CNFL: r = 0.553, p = 0.023). Corneal confocal microscopy CCM reveals sensory neurodegeneration in SMA, thereby supporting a multisystem view of the disorder. Subclinical small nerve fibre damage correlated with motor function. Thus, CCM may be ideally suited for treatment monitoring and prognosis.
Sections du résumé
BACKGROUND
5q Spinal muscular atrophy (SMA) is a progressive, inherited, and severely disabling - yet treatable - motor neuron disease. Although treatment options have evolved in recent years, biomarkers for treatment monitoring and prognosis prediction remain elusive. Here, we investigated the utility of corneal confocal microscopy (CCM), a non-invasive imaging technique to quantify small corneal nerve fibres in vivo, as a diagnostic tool in adult SMA.
METHODS
In this cross-sectional study, 19 patients with SMA type 3 and 19 healthy controls underwent CCM to measure corneal nerve fibre density (CNFD), corneal nerve fibre length (CNFL), and corneal nerve branch density (CNBD), as well as corneal immune cell infiltration. Hammersmith Functional Motor Scale Expanded (HFMSE) and Revised Upper Limb Module (RULM) scores and a 6-Minute Walk Test (6MWT) were conducted to explore any correlation between CCM findings and motor function.
RESULTS
Corneal nerve fibre parameters were decreased in SMA patients versus healthy controls (CNFD: p = 0.030; CNFL: p = 0.013; CNBD: p = 0.020) in the absence of relevant immune cell infiltration. CNFD and CNFL correlated with HFMSE scores (CNFD: r = 0.492, p = 0.038; CNFL: r = 0.484, p = 0.042) and distance covered in the 6MWT (CNFD: r = 0.502, p = 0.042; CNFL: r = 0.553, p = 0.023).
CONCLUSIONS
Corneal confocal microscopy CCM reveals sensory neurodegeneration in SMA, thereby supporting a multisystem view of the disorder. Subclinical small nerve fibre damage correlated with motor function. Thus, CCM may be ideally suited for treatment monitoring and prognosis.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2821-2827Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Lefebvre S, Bürglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155-165. doi:10.1016/0092-8674(95)90460-3
Lunn M, Wang C. Spinal muscular atrophy. Lancet. 2008;371:2120-2133. doi:10.1016/S0140-6736(08)60921-6
Dubowitz V. Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype. Eur J Paediatr Neurol. 1999;3:49-51. doi:10.1053/ejpn.1999.0181
MacLeod M, Taylor J, Lunt P, Matthews C, Robb S. Prenatal onset spinal muscular atrophy. Eur J Paediatr Neurol. 1999;3:65-72. doi:10.1053/ejpn.1999.0184
Mercuri E, Pera M, Scoto M, et al. Spinal muscular atrophy - insights and challenges in the treatment era. Nat Rev Neurol. 2020;16:706-715. doi:10.1038/s41582-020-00413-4
Nusinersen HS. first global approval. Drugs. 2017;77:473-479. doi:10.1007/s40265-017-0711-7
Hagenacker T, Wurster C, Günther R, et al. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study. Lancet Neurol. 2020;19(4):317-325. doi:10.1016/S1474-4422(20)30037-5
Finkel R, Mercuri E, Darras B, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377:1723-1732. doi:10.1056/NEJMoa1702752
Dhillon S. Risdiplam: first approval. Drugs. 2020;80:1853-1858. doi:10.1007/s40265-020-01410-z
Hoy S. Onasemnogene abeparvovec: first global approval. Drugs. 2019;79:1255-1262. doi:10.1007/s40265-019-01162-5
Sansone V, Walter M, Attarian S, et al. Measuring outcomes in adults with spinal muscular atrophy - challenges and future directions - meeting report. J Neuromuscul Dis. 2020;7:523-534. doi:10.3233/JND-200534
Smeriglio P, Langard P, Querin G, et al. The identification of novel biomarkers is required to improve adult SMA patient stratification, diagnosis and treatment. J Pers Med. 2020;10:75. doi:10.3390/jpm10030075
Groen E, Talbot K, Gillingwater T. Advances in therapy for spinal muscular atrophy: promises and challenges. Nat Rev Neurol. 2018;14:214-224. doi:10.1038/nrneurol.2018.4
Chaytow H, Huang Y, Gillingwater T, et al. The role of survival motor neuron protein (SMN) in protein homeostasis. Cell Mol Life Sci. 2018;75:3877-3894. doi:10.1007/s00018-018-2849-1
Fletcher E, Simon C, Pagiazitis J, et al. Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy. Nat Neurosci. 2017;20:905-916. doi:10.1038/nn.4561
Hunter G, Sarvestany AA, Roche S, et al. SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy. Hum Mol Genet. 2014;23:2235-2250. doi:10.1093/hmg/ddt612
Mentis G, Blivis D, Liu W, et al. Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron. 2011;69:453-467. doi:10.1016/j.neuron.2010.12.032
Zhou C, Feng Z, Ko C. Defects in motoneuron-astrocyte interactions in spinal muscular atrophy. J Neurosci. 2016;36:2543-2553. doi:10.1523/JNEUROSCI.3534-15.2016
Petropoulos I, Ponirakis G, Khan A, et al. Corneal confocal microscopy: ready for prime time. Clin Exp Optom. 2020;103:265-277. doi:10.1111/cxo.12887
Hossain P, Sachdev A, Malik R. Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet. 2005;366:1340-1343. doi:10.1016/S0140-6736(05)67546-0
Stettner M, Hinrichs L, Guthoff R, et al. Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy. Ann Clin Transl Neurol. 2016;3:88-100. doi:10.1002/acn3.275
Fleischer M, Lee I, Erdlenbruch F, et al. Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy. J Neuroinflammation. 2021;18:89. doi:10.1186/s12974-021-02130-1
Mimura T, Amano S, Fukuoka S, et al. In vivo confocal microscopy of hereditary sensory and autonomic neuropathy. Curr Eye Res. 2008;33:940-945. doi:10.1080/02713680802450992
Tavakoli M, Marshall A, Banka S, et al. Corneal confocal microscopy detects small-fiber neuropathy in Charcot-Marie-tooth disease type 1A patients. Muscle Nerve. 2012;46:698-704. doi:10.1002/mus.23377
Lim S, Ferdousi M, Kalteniece A, et al. Corneal confocal microscopy identifies Parkinson's disease with more rapid motor progression. Mov Disord. 2021;36:1927-1934. doi:10.1002/mds.28602
Misra S, Kersten H, Roxburgh R, et al. Corneal nerve microstructure in Parkinson's disease. J Clin Neurosci. 2017;39:53-58. doi:10.1016/j.jocn.2017.02.033
Petropoulos I, Kamran S, Li Y, et al. Corneal confocal microscopy: an imaging endpoint for axonal degeneration in multiple sclerosis. Invest Ophthalmol Vis Sci. 2017;58:3677-3681. doi:10.1167/iovs.17-22050
Petropoulos I, Fitzgerald K, Oakley J, et al. Corneal confocal microscopy demonstrates axonal loss in different courses or multiple sclerosis. Sci Rep. 2021;11:21688. doi:10.1038/s41598-021-01226-1
Fu J, He J, Zhang Y, et al. Small fiber neuropathy for assessment of disease severity in amyotrophic lateral sclerosis: corneal confocal microscopy findings. Orphanet J Rare Dis. 2022;17:7. doi:10.1186/s13023-021-02157-w
Ferrari G, Grisan E, Scarpa F, et al. Corneal confocal microscopy reveals trigeminal small sensory fiber neuropathy in amyotrophic lateral sclerosis. Front Aging Neurosci. 2014;6:278. doi:10.3389/fnagi.2014.00278
Zhivov A, Stave J, Vollmar B, Guthoff R. In vivo confocal microscopic evaluation of Langerhans cell density and distribution in the normal human corneal epithelium. Graefes Arch Exp Clin Ophthalmol. 2005;243:1056-1061. doi:10.1097/ICO.0b013e31802e3b55
Chen W, Hara K, Tian Q, Zhao K, Yoshitomi T. Existence of small slow-cycling Langerhans cells in the limbal basal epithelium that express ABCG2. Exp Eye Res. 2007;84:626-634. doi:10.1016/j.exer.2006.11.006
Mayer W, Irschick U, Moser P, et al. Characterization of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. Invest Ophthalmol Vis Sci. 2007;48:4459-4467. doi:10.1167/iovs.06-1184
Smith A, Kim G, Porzio M, et al. Corneal confocal microscopy is efficient, well-tolerated, and reproducible. J Peripher Nerv Syst. 2013;18:54-58. doi:10.1111/jns5.12008
Chen X, Graham J, Dabbah M, et al. Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diabetes Care. 2015;38:1138-1144. doi:10.2337/dc14-2422
Moulton E, Borsook D. C-fiber assays in the cornea vs. skin. Brain Sci. 2019;9:320. doi:10.3390/brainsci9110320
Shafey D, Côté P, Kothary R. Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology. Exp Cell Res. 2005;311:49-61. doi:10.1016/j.yexcr.2005.08.019
Cifuentes-Diaz C, Frugier T, Tiziano F, et al. Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. J Cell Biol. 2001;152:1107-1114. doi:10.1083/jcb.152.5.1107
Hayhurst M, Wagner A, Cerletti M, et al. A cell-autonomous defect in skeletal muscle satellite cells expressing low levels of survival of motor neuron protein. Dev Biol. 2012;368:323-334. doi:10.1016/j.ydbio.2012.05.037
Martínez-Hernández R, Soler-Botija C, Also E, et al. The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation. J Neuropathol Exp Neurol. 2009;68:474-481. doi:10.1097/NEN.0b013e3181a10ea1
Brogna C, Cristiano L, Verdolotti T, et al. MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients. J Neurol. 2020;267:898-912. doi:10.1007/s00415-019-09646-w
Pro S, Tozzi A, D'Amico A, et al. Age-related sensory neuropathy in patients with spinal muscular atrophy type 1. Muscle Nerve. 2021;64:599-603. doi:10.1002/mus.27389
Rudnik-Schöneborn S, Goebel H, Schlote W, et al. Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy. Neurology. 2003;60:983-987. doi:10.1212/01.wnl.0000052788.39340.45
Duman O, Uysal H, Skjei K, Kizilay F, Karauzum S, Haspolat S. Sensorimotor polyneuropathy in patients with SMA type-1: electroneuromyographic findings. Muscle Nerve. 2013;48:117-121. doi:10.1002/mus.23722
Yonekawa T, Komaki H, Saito Y, Sugai K, Sasaki M. Peripheral nerve abnormalities in pediatric patients with spinal muscular atrophy. Brain Dev. 2013;35:165-171. doi:10.1016/j.braindev.2012.03.009
Jablonka S, Karle K, Sandner B, Andreassi C, von Au K, Sendtner M. Distinct and overlapping alterations in motor and sensory neurons in a mouse model of spinal muscular atrophy. Hum Mol Genet. 2006;15:511-518. doi:10.1093/hmg/ddi467
Hamilton G, Gillingwater T. Spinal muscular atrophy: going beyond the motor neuron. Trends Mol Med. 2012;19:40-50.
Thimm A, Carpinteiro A, Oubari S, et al. Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosis. Ann Clin Transl Neurol. 2022;9:853-863. doi:10.1002/acn3.51565
Zhang Y, Liu Z, Zhang Y, et al. Corneal sub-basal whorl-like nerve plexus: a landmark for early and follow-up evaluation in transthyretin familial amyloid polyneuropathy. Eur J Neurol. 2021;28:630-638. doi:10.1111/ene.14563